Logo Image
Opinion|Videos|September 30, 2024

Administration of FDA-Approved Fecal Microbiota Transplants for C. difficile Infections in Clinical Practice

Matthew D. Sims, MD, PhD, FACP, FIDSA, discusses how fecal microbiota transplantation therapies are administered and shares his clinical experience.

Episodes in this series

Video content above is prompted by the following:

  • How are these FMT therapies administered?
  • What has your experience been with administering each of these therapies?
  • What have you heard from your patients?

Related to this article

View more
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
Read more
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Read more